Balance Training as an Adjunct to Methylphenidate: A Randomized Controlled Pilot Study of Behavioral Improvement Among Children With ADHD in China

Balance Training as an Adjunct to Methylphenidate: A Randomized Controlled Pilot Study of Behavioral Improvement Among Children With ADHD in China

Objective: This study aimed to compare the therapeutic effects of two different approaches to attention deficit hyperactivity disorder (ADHD): (1) methylphenidate (MPH) treatment combined with balance training, and (2) MPH monotherapy.Methods: The study was based on a randomized, single-blind trial...

Full description

Bibliographic Details
Main Authors:	Lei Feng, Yuanchun Ren, Jia Cheng, Yufeng Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-01-01
Series:	Frontiers in Psychiatry
Subjects:	ADHD methylphenidate balance training pilot randomized controlled trial efficacy
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2020.552174/full

Similar Items

A randomised controlled trial of combined EEG feedback and methylphenidate therapy for the treatment of ADHD
by: Li Li, et al.
Published: (2013-08-01)

Effects of 16 Weeks of Methylphenidate Treatment on Actigraph-Assessed Sleep Measures in Medication-Naive Children With ADHD
by: Michelle M. Solleveld, et al.
Published: (2020-02-01)

Potential Negative Effects of Dextromethorphan as an Add-On Therapy to Methylphenidate in Children With ADHD
by: Wei-Chen Chuang, et al.
Published: (2019-06-01)

The Risk of Methylphenidate Pharmacotherapy for Adults with ADHD
by: Rafał Bieś, et al.
Published: (2023-09-01)

Effects of one single-dose methylphenidate compared to one single-dose placebo on QbTest performance in adults with untreated ADHD: a randomized controlled trial
by: Lennart Jansson, et al.
Published: (2023-10-01)

Atomoxetine and Methylphenidate Treatment in ADHD
by: Snircova E., et al.
Published: (2015-05-01)

Methylphenidate does not restore the reduced serum BDNF levels in ADHD children
by: María-del-Carmen Augustin-Morales, et al.
Published: (2012-09-01)

Alpha/beta-gamma decoupling in methylphenidate medicated ADHD patients
by: Nowell Zammit, et al.
Published: (2023-09-01)

The Knowledge and Attitude of the Parents of Children with ADHD toward Methylphenidate (Ritalin)
by: Sanaz Noroozi, et al.
Published: (2023-04-01)

Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity
by: Huss M, et al.
Published: (2017-07-01)

ADHD diagnosis and methylphenidate consumption in children and adolescents: A systematic analysis of health databases in France over the period 2010–2019
by: Sébastien Ponnou, et al.
Published: (2022-10-01)

Randomised controlled trial of the short-term effects of OROS-methylphenidate on ADHD symptoms and behavioural outcomes in young male prisoners with attention-deficit/hyperactivity disorder (CIAO-II)
by: Philip Asherson, et al.
Published: (2019-12-01)

Editorial: Attention and Methylphenidate
by: Avi Avital, et al.
Published: (2020-04-01)

Prediction of sleep side effects following methylphenidate treatment in ADHD youth
by: Jae Hyun Yoo, et al.
Published: (2020-01-01)

Regional brain volume predicts response to methylphenidate treatment in individuals with ADHD
by: Jung-Chi Chang, et al.
Published: (2021-01-01)

Effects of 12-Week Methylphenidate Treatment on Neurometabolism in Adult Patients with ADHD: The First Double-Blind Placebo-Controlled MR Spectroscopy Study
by: Simon Maier, et al.
Published: (2020-08-01)

Decreased Risk of Influenza in Child and Adolescent Patients with Attention-Deficit Hyperactivity Disorder Following Methylphenidate Treatment: A Nationwide Cohort Study in Taiwan
by: Lee H, et al.
Published: (2020-05-01)

A Quasi-Experimental Trial in Comparison of Duloxetine and Methylphenidate in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder
by: Nasrin Dodangi, et al.
Published: (2016-06-01)

Methylphenidate does not affect convergent and divergent creative processes in healthy adults
by: Matthijs Baas, et al.
Published: (2020-01-01)

Methylphenidate Restores Behavioral and Neuroplasticity Impairments in the Prenatal Nicotine Exposure Mouse Model of ADHD: Evidence for Involvement of AMPA Receptor Subunit Composition and Synaptic Spine Morphology in the Hippocampus
by: Darwin Contreras, et al.
Published: (2022-06-01)

Decrease in brain complexity with methylphenidate treatment in boys diagnosed with attention deficit hyperactivity disorder: An entropy-based qeeg analysis
by: F.H. Çetin, et al.
Published: (2021-04-01)

Different basal concentration and different response of BDNF to prolonged release methylphenidate between ADHD subtypes
by: Antonio Molina-Carballo, et al.
Published: (2012-09-01)

Does 20 mg long-acting methylphenidate alter blood pressure and heart rate in children with ADHD?
by: Tjhin Wiguna, et al.
Published: (2011-10-01)

Effect of Methylphenidate on State Anxiety in Children With ADHD-A Single Dose, Placebo Controlled, Crossover Study
by: Maya Kritchman, et al.
Published: (2019-05-01)

Emotional dysregulation and callous unemotional traits as possible predictors of short-term response to methylphenidate monotherapy in drug-naïve youth with ADHD
by: Gabriele Masi, et al.
Published: (2020-07-01)

Methylphenidate in ADHD and Refractory Epilepsy
by: J Gordon Millichap, et al.
Published: (2014-02-01)

A comparison of effectiveness of regulation of working memory function and methylphenidate on remediation of attention deficit hyperactivity disorder (ADHD).
by: Mohammad Reza Mohammadi, et al.
Published: (2014-03-01)

Attention Deficit Hyperactivity Disorder and Methylphenidate: When Society Misunderstands Medicine
by: David D. Kaminester
Published: (2020-12-01)

The Decrease in Human Endogenous Retrovirus-H Activity Runs in Parallel with Improvement in ADHD Symptoms in Patients Undergoing Methylphenidate Therapy
by: Cipriani Chiara, et al.
Published: (2018-10-01)

Increase in brain connectivity with methylphenidate treatment in boys diagnosed with attention deficit hyperactivity disorder: A coherence-based qeeg analysis
by: F.H. Çetin, et al.
Published: (2021-04-01)

Associations between CES1 variants and dosing and adverse effects in children taking methylphenidate
by: Jacob T. Brown, et al.
Published: (2023-01-01)

Limited usefulness of neurocognitive functioning indices as predictive markers for treatment response to methylphenidate or neurofeedback@home in children and adolescents with ADHD
by: Anna Kaiser, et al.
Published: (2024-01-01)

Behavioral, Neurochemical and Developmental Effects of Chronic Oral Methylphenidate: A Review
by: Daniela Senior, et al.
Published: (2023-03-01)

Low Doses of Melatonin to Improve Sleep in Children with ADHD: An Open-Label Trial
by: Ana Checa-Ros, et al.
Published: (2023-06-01)

Effect of Methylphenidate in ADHD with Epilepsy or with EEG Abnormalities without Seizures
by: J Gordon Millichap
Published: (2003-05-01)

NIRS Hemodynamic Response to Methylphenidate in Children with Attention Aeficit Hyperactivity Disorder: First Administration, Titration Phase and Associations with Clinical Severity
by: A. Crippa, et al.
Published: (2022-06-01)

Use of Virtual Reality Working Memory Task and Functional Near-Infrared Spectroscopy to Assess Brain Hemodynamic Responses to Methylphenidate in ADHD Children
by: Sooah Jang, et al.
Published: (2021-01-01)

Long-term neurocognitive effects of methylphenidate in patients with attention deficit hyperactivity disorder, even at drug-free status
by: Huang Yu-Shu, et al.
Published: (2012-11-01)

Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysis
by: Jain Rakesh, et al.
Published: (2011-11-01)

Effects of methylphenidate on height, weight and blood biochemistry parameters in prepubertal boys with attention deficit hyperactivity disorder: an open label prospective study
by: Çevikaslan Ahmet, et al.
Published: (2021-01-01)